| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Case of Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion with Partial Response to Crizotinib
|
Shen, Qian
|
|
|
22 |
6 |
p. e799-e803
|
artikel
|
| 2 |
Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy
|
Yu, James
|
|
|
22 |
6 |
p. e856-e858
|
artikel
|
| 3 |
Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments
|
Reuss, Joshua E.
|
|
|
22 |
6 |
p. 483-499
|
artikel
|
| 4 |
A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer
|
Byers, Lauren Averett
|
|
|
22 |
6 |
p. 531-540
|
artikel
|
| 5 |
A Randomized Phase III Study of Pembrolizumab Versus Pembrolizumab-Carboplatin-Pemetrexed for Locally Advanced or Metastatic Nonsquamous Non-small-cell Lung Cancer with PD-L1 50% or more (LAPLACE-50): Study Protocol
|
Kogure, Yoshihito
|
|
|
22 |
6 |
p. e921-e924
|
artikel
|
| 6 |
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung Cancer
|
Arrieta, Oscar
|
|
|
22 |
6 |
p. 510-522
|
artikel
|
| 7 |
Biomarker-Directed Phase II Platform Study in Patients With EGFR Sensitizing Mutation-Positive Advanced/Metastatic Non-Small Cell Lung Cancer Whose Disease Has Progressed on First-Line Osimertinib Therapy (ORCHARD)
|
Yu, Helena A.
|
|
|
22 |
6 |
p. 601-606
|
artikel
|
| 8 |
Black Hairy Tongue After Immune Checkpoint Inhibitors in NSCLC: A Case Report and Review of the Literature
|
Cecchi, Cristina
|
|
|
22 |
6 |
p. e804-e807
|
artikel
|
| 9 |
Bloodborne Cytokines for Predicting Clinical Benefits and Immune-Related Adverse Events in Advanced Non-Small Cell Lung Cancer Treated With Anti-Programmed Cell Death 1 Inhibitors
|
Oyanagi, Jun
|
|
|
22 |
6 |
p. e833-e841
|
artikel
|
| 10 |
Clinical Value and Pathologic Basis of Cystic Airspace Within Subsolid Nodules Confirmed as Lung Adenocarcinomas by Surgery
|
Wang, Bin
|
|
|
22 |
6 |
p. e881-e888
|
artikel
|
| 11 |
Co-occurring MET Amplification Predicts Inferior Clinical Response to First-Line Erlotinib in Advanced Stage EGFR-Mutated NSCLC Patients
|
Clement, Michelle S.
|
|
|
22 |
6 |
p. e870-e877
|
artikel
|
| 12 |
Description of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky
|
Brainson, Christine F.
|
|
|
22 |
6 |
p. e911-e920
|
artikel
|
| 13 |
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)
|
Socinski, Mark A.
|
|
|
22 |
6 |
p. 549-561
|
artikel
|
| 14 |
Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib
|
Ji, Jingran
|
|
|
22 |
6 |
p. e851-e855
|
artikel
|
| 15 |
Editorial Board
|
|
|
|
22 |
6 |
p. A1
|
artikel
|
| 16 |
Effect of Immune-Related Adverse Events and Pneumonitis on Prognosis in Advanced Non–Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-analysis
|
Li, Yanlin
|
|
|
22 |
6 |
p. e889-e900
|
artikel
|
| 17 |
EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non–Small Cell Lung Cancer
|
Leal, Jose Luis
|
|
|
22 |
6 |
p. e859-e869
|
artikel
|
| 18 |
EGFR L718V (+)/T790M (–) as a Mechanism of Resistance in Patients with Metastatic Non–small-cell Lung Cancer with EGFR L858R Mutations
|
Raez, Luis E.
|
|
|
22 |
6 |
p. e817-e819
|
artikel
|
| 19 |
Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
|
Riess, Jonathan W
|
|
|
22 |
6 |
p. 541-548
|
artikel
|
| 20 |
Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer
|
Merkhofer, Cristina M.
|
|
|
22 |
6 |
p. 523-530
|
artikel
|
| 21 |
Lung Adenocarcinoma With Primary LIMD1-BRAF Fusion Treated With MEK Inhibitor: A Case Report
|
Wang, Cheng-You
|
|
|
22 |
6 |
p. e878-e880
|
artikel
|
| 22 |
Micropapillary Predominance Is a Risk Factor for Brain Metastasis in Resected Lung Adenocarcinoma
|
Shigenobu, Takao
|
|
|
22 |
6 |
p. e820-e828
|
artikel
|
| 23 |
Molecular Risk Stratification is Independent of EGFR Mutation Status in Identifying Early-Stage Non–Squamous Non–Small Cell Lung Cancer Patients at Risk for Recurrence and Likely to Benefit From Adjuvant Chemotherapy
|
Woodard, Gavitt A.
|
|
|
22 |
6 |
p. 587-595
|
artikel
|
| 24 |
Palmoplantar Pustulosis Caused by Immune-Checkpoint Inhibitors
|
Furuta, Hiromi
|
|
|
22 |
6 |
p. e829-e832
|
artikel
|
| 25 |
Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L)
|
Hamada, Akira
|
|
|
22 |
6 |
p. 596-600
|
artikel
|
| 26 |
Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
|
Kao, Chester
|
|
|
22 |
6 |
p. 500-509
|
artikel
|
| 27 |
Pulmonary Cylindromas in CYLD Cutaneous Syndrome: A Rare Differential Diagnosis of Pulmonary Adenoid Cystic Carcinoma
|
Bülau, Judith E.
|
|
|
22 |
6 |
p. e795-e798
|
artikel
|
| 28 |
Racial Differences in Lung Cancer Screening Beliefs and Screening Adherence
|
Barta, Julie A.
|
|
|
22 |
6 |
p. 570-578
|
artikel
|
| 29 |
Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
|
Fisher, Amanda
|
|
|
22 |
6 |
p. e842-e850
|
artikel
|
| 30 |
Role of Postoperative Radiotherapy in the Management for Resected NSCLC – Decision Criteria in Clinical Routine Pre- and Post-LungART
|
Süveg, Krisztian
|
|
|
22 |
6 |
p. 579-586
|
artikel
|
| 31 |
Significance of Brain Imaging for Staging in Patients With Clinical Stage T1-2 N0 Non–Small-Cell Lung Cancer on Positron Emission Tomography/Computed Tomography
|
Saito, Go
|
|
|
22 |
6 |
p. 562-569
|
artikel
|
| 32 |
Table of Contents
|
|
|
|
22 |
6 |
p. A3-A8
|
artikel
|
| 33 |
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists
|
Waterhouse, David M.
|
|
|
22 |
6 |
p. e901-e910
|
artikel
|
| 34 |
Utility of Prophylactic Cranial Irradiation for Extensive-Stage Small-Cell Lung Cancer in the MRI Screening Era
|
Keller, Andrew
|
|
|
22 |
6 |
p. e808-e816
|
artikel
|
Tijdschrift beschrijving